Form 4: Standard BioTools CEO Michael Egholm Reports Stock Transactions
SEC Form 4 Filing
Michael Egholm, President & CEO of Standard BioTools Inc., reports disposition of shares to cover tax obligations arising from vesting of restricted stock units.
Summary
- On May 20, 2025, shares were withheld from Michael Egholm to cover tax obligations related to the vesting of restricted stock units (RSUs).
- On May 21, 2025, Egholm sold shares to satisfy tax withholding obligations from RSUs vesting on March 21, 2025.
- The sale price ranged from $1.015 to $1.05 per share, with a weighted average sales price of $1.03.
- Following these transactions, Egholm directly owns 2,751,780 shares of Standard BioTools Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. The transactions are related to tax obligations and do not necessarily reflect a change in the executive's outlook on the company.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions. It reflects the standard practice of executives managing their equity compensation and related tax obligations. It doesn't necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| May 20, 2024 | Date of original RSU grant, reported on Form 4 filed on May 21, 2024. |
| March 21, 2025 | Date of RSU grant, reported on Form 4 filed on March 24, 2025. |
| May 20, 2025 | Shares withheld to satisfy tax obligations from RSU vesting. |
| May 21, 2025 | Shares sold to satisfy tax obligations from RSU vesting. |
| May 22, 2025 | Date of Form 4 signature. |
Keywords
Form 4, insider trading, Michael Egholm, Standard BioTools Inc., LAB, stock sale, restricted stock units, RSUs, tax obligations, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.